Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"In the past, if you wanted this type of information, you hired a
third-party agency to survey your customers. Not only did you pay a third
party to collect the data, but you wondered how good was it really? Even
though you hired an outside company, customers filling out the survey still
knew who was sponsoring the research."
PAUL SIDHU VP OF MARKETING AND STRATEGY FOR DSM  
DIA 2013 49th Annual Meeting
June 23-27 Boston, MA |
Anu's Laboratories Bio Basic BioVectra, Inc. ExxPharma Therapeutics LLC Obiter Research, LLC Girindus Solvay Organics OmegaChem Phyton Biotech, LLC Pressure Chemical Co. Roche Carolina, Inc.
SAI Life Sciences offers a range of drug discovery and development services including synthetic and medicinal chemistry, chemical development and manufacturing, DMPK, toxicology, and formulation. The company’s synthetic and medicinal chemistry offerings include design and synthesis of focused libraries; preparation of building blocks and starting materials, synthesis of reference compounds and metabolites; and design and synthesis of analogues to support lead generation and optimization. The company has two approved manufacturing facilities that can support a range of reactions as well as large-scale hydrogenation and separation / purification.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
